MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Functional Proteomic Analysis of Leukocytes from Parkinson’s Disease Patients: A Clinical Perspective on Biomarkers Identification

    N. Woldmar, B. Fadel, G. Poralla, L. Giacomin, J. Evaristo, F. Nogueira, A. Rosso, L. Pizzatti (Rio de Janeiro, Brazil)

    Objective: The aim of this work was to identify proteomic profiles associated with specific Parkinson’s disease (PD) clinical groups in leukocytes of patients from Rio…
  • 2019 International Congress

    Microglia as modulators of exosomal alpha-synuclein transmission

    Y. Xia, T. Wang, GX. Zhang, JS. Huang, N. Xiong, L. Liu, F. Wan, L. Kou, SJ. Yin, JJ. Hu, YD. Sun, JW. Wu (Wuhan, China)

    Objective: It is highly desirable to make clear the underlying mechanism of exosomes-involved communication in the synucleinopathy pathogenesis. Background: Emerging evidence suggests that exogenous pathogenic…
  • 2019 International Congress

    Hypermethylation of PGC-1α in peripheral blood leukocytes of patients with Parkinson’s disease

    X. Yang, SQ. Xu, W. Qian, Q. Xiao (Shanghai, China)

    Objective: We aimed to explore the hypothesis that the PGC-1α variants are associated with its promoter methylations level thus affecting the PGC-1α mRNA expression. We…
  • 2019 International Congress

    NS-PARK cohort: a nationwide real life longitudinal cohort of PD patients

    H. Alfaisal, F. Durif, S. Thobois, L. Defebvre, JP. Azulay, P. Couratier, P. Damier, D. Devos, S. Drapier, A. Doe Demaindreville, S. Frismand, C. Geny, C. Giordana, JL. Houeto, P. Krystkowiak, E. Magnin, D. Maltête, W. Meissner, C. Moreau, E. Moro, P. Remy, C. Thiriez, C. Tranchant, F. Viallet, M. Vidailhet, E. Dellapina, V. Chaigneau, C. Dongmo, F. Tubach, Y. de Rycke, O. Rascol, JC. Corvol (Paris, France)

    Objective: To describe the Parkinson disease (PD) population followed by the 25 expert centers for PD in France. Background: NS-PARK is the clinical research network…
  • 2019 International Congress

    Longitudinal analysis of the relation between trajectories of dopaminergic agonists use and BMI in Parkinson’s disease

    F. Artaud, PC. Lee, M. Vidailhet, JC. Corvol, A. Elbaz (Saint-Aubin, France)

    Objective: To describe the longitudinal relation between dopaminergic agonists (DA) use and change of BMI in a longitudinal cohort of PD patients followed annually up…
  • 2019 International Congress

    Self-reported demographic, genetic, symptom, and treatment data of subjects in the Fox Trial Finder

    M. Bailey, A. Gera, Y. Liu, B. Ouyang, G. Pal (Chicago, IL, USA)

    Objective: To examine the characteristics of subjects within the Fox Trial Finder (FTF) database. Background: FTF is an online, patient driven database by which Parkinson’s…
  • 2019 International Congress

    Advanced Stage of Parkinson’s Disease: From Identification to Characterization and Disease Burden Assessment Using a Nationwide Database

    Y. Barer, T. Gurevich, G. Chodick, N. Giladi, R. Gross, R. Cohen, L. Bergmann, Y. Jalundhwala, V. Shalev, A. Thaler (Tel Aviv-Yafo, Israel)

    Objective: To identify and describe PD patients who were prescribed intensified therapy and compare their burden of disease with mild-moderate PD patients. Background: Real-world data…
  • 2019 International Congress

    Movement disorders in neurologic consultation of Marrakesh University Hospital

    L. Berrhoute, J. El Mesbahy, N. Kissani (Marrakesh, Morocco)

    Objective: Describing the epidemiological and clinical aspects of the movement’s disorders in Marrakesh. Analyzing difficulties of management of this disease. Comparing our data with international…
  • 2019 International Congress

    Establishing the first apomorphine treatment registry in Thailand: prospective data collection to inform optimal care of Parkinson’s disease patients

    R. Bhidayasiri, O. Phokaewvarangkul, K. Boonpang, T. Boonmongkol, Y. Thongchuam, N. Kantachadvanich, J. Sringean, P. Panyakaew, P. Jagota (Bangkok, Thailand)

    Objective: To establish a registry of PD patients in Thailand treated with subcutaneous apomorphine (APO) injection or infusion to allow prospective data collection from the…
  • 2019 International Congress

    Clinical profile of idiopathic Parkinson’s disease in patients admitted to Mohamed VI University Hospital center of Marrakech

    A. Boudanga, N. Jalami, M. Chraa, N. Kissani (Marrakech, Morocco)

    Objective: Prevalence studies in different parts of the world have shown that Parkinson's disease is a pathology that has a very important impact in older…
  • « Previous Page
  • 1
  • …
  • 1358
  • 1359
  • 1360
  • 1361
  • 1362
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley